AUA 2017: Urine Based Rapid Molecular Diagnosis of Zika Virus
Boston, MA (UroToday.com) Best poster of the session on Infections/Inflammation/Cystic Disease of the Genitourinary Tract: Kidney & Bladder II was presented by Laura Lamb, PhD from Oakland University William Beaumont School of Medicine.
AUA 2017: Practice patterns across specialties in the treatment of women with recurrent UTIs in an academic healthcare system
Boston, MA (UroToday.com) Matthew Sterling, MD from the University of Pennsylvania presented a poster entitled "Practice patterns across specialties in the treatment of women with recurrent UTIs in an academic healthcare system".
AUA 2017: Early Discharge Following Decompression For Sepsis and an Obstructing Stone? A Multi-institutional Study to Identify Predictors of Antibiotic Sensitivity
Boston, MA (UroToday.com) Treatment for patients presenting with sepsis due to an obstructing stone requires urgent urinary tract decompression. Following this, patients are hospitalized for hemodynamic support and broad spectrum antibiotics. Urine culture results are used to tailor outpatient antibiotic therapy.
AUA 2017: Endometriosis – Urinary Tract Involvement and Predictive Factors for Major Surgery
Boston, MA (UroToday.com) Endometriosis affects 5-15% of premenopausal females. Involvement of the urinary tract by endometriosis (UTE) is present in 1-2% of patients. The presented study assessed the severity and surgical treatment of deep infiltrating endometriosis (DIE) with involvement of the urinary tract. Additionally the study also aimed to decipher the existence of predictive factors for major surgery in patients with UTE.
AUA 2017: Risk factor assessment for fluoroquinolone resistant E. coli (FRE) in bowel flora is not sufficiently discriminatory: the case for a pre-biopsy rectal swab in all patients
Boston, MA (UroToday.com) Dr. Michael Holmes and colleagues report that there has been a significant rise in infectious complications from transrectal ultrasound guided (TRUS) biopsies due to fluoroquinolone resistant E. coli (FRE) in the bowel flora. The authors sought to discover potential high risk patient factors that may increase the incidence of FRE or sepsis, post biopsy and sought to answer the question: Can we identify a high risk group for FRE and disregard the rest?
AUA 2017: A Randomized, Controlled Trial of Active vs. Passive Voiding Trials
Boston, MA (UroToday.com) James Mills, MD, MSCR from the University of Virginia presented a poster entitled “A Randomized, Controlled Trial of Active vs. Passive Voiding Trials.”